Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 6,054 shares at $16.55 ($100K) on 2018-03-07, disclosed to the SEC on 2018-03-09.
Seasonal sale ($100k) by Chief Operating Officer — this insider has traded STML in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.55 | 3,027 | $50K | 50.0% |
| 2 | $16.55 | 3,027 | $50K | 50.0% |
| Total | $16.55 avg | 6,054 | $100K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |